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Objective: Immune cells are involved in the pathogenesis of osteoarthritis (OA). We examined the effects
of T helper (Th) cells, which induce the expression of macrophage inﬂammatory protein (MIP-1g), on the
progression of OA.
Design: Using anterior cruciate ligament-transection (ACLT), we induced OA in one hind-leg knee joint of
B6 mice. The CD4þ T cells from splenocytes and synovium were ﬂow-cytometrically and immuno-
chemically evaluated, respectively. The knee joints were histologically assessed for manifestations of OA.
MIP-1g levels and nuclear factor-kB (NF-kB) in the knee joints were measured using enzyme-linked
immunosorbent and immunoblotting assays, respectively; osteoclastogenesis was detected by tartrate-
resistant acid phosphatase (TRAP) staining. The inﬂammatory responses and MIP-1g expression were
examined using immunohistochemistry.
Results: The number of CD4þ T cells and the expression of interferon-g (IFN-g) increased during OA onset
(30 days after ACLT) and then decreased at a later stage of OA (90 days after ACLT). Tissue damage
induced by CD4þ T cells was evident at the later stage. The activation of CD4þ T cells induced the
expression of MIP-1g and NF-kB. The expression of MIP-1g can be detected in synovium which CD4þ T
cells were inﬁltrated. The increased MIP-1g expression caused an increase in the number of osteoclasts in
joints. The regulation of CD4þ T cells was accompanied by increased macrophage inﬁltration and matrix
metalloproteinase (MMP)-9 expression. Histopathological examinations revealed that CD4þ T cell
knockout (CD4/) mice had less expression of MIP-1g and slower cartilage degeneration than control
mice had.
Conclusions: CD4þ T cells were activated during the onset of OA, but cartilage damage was more
prominent at a later stage. CD4þ T cells were involved in the pathogenesis of OA: they induced MIP-1g
expression and subsequent osteoclast formation.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a progressive disorder of articular carti-
lage. Strong evidence indicates that the structural changes in OA
are due to a biomechanical alteration1. The factors that cause OA
are multiple; they include age, weight, sex, bone density, trauma
history, and gene-based susceptibility2. Degeneration of joint: J.-L. Hsieh, Department of
gy, 89 Wun-hwa 1st Street,
7x525; Fax: 886-6-267-8119.
. Hsieh).
s Research Society International. Pcartilage, with concomitant changes in synovium and subchondral
bone, is the major feature of OA. The proinﬂammatory mediators
induced in OA synovium cause synovial hypertrophy and hyper-
plasia along with an increased number of lining cells and inﬁl-
trating inﬂammatory cells. We previously3,4 showed that the
intraarticular injection of adenovirus-encoding genes with an anti-
inﬂammatory effect, adenoviral vector encoding kallistatin
(AdHKBP) and adenoviral vector encoding thrombospondin-1
(AdTSP-1), signiﬁcantly reduced the severity of OA in rat models.
Accumulating evidence suggests that T helper (Th) cells are
essential in inﬂammatory responses and cartilage damage5. The
immune response induced by Th cells is evident from the pres-
ence of Th cell inﬁltrates, the expression of Th cell activationublished by Elsevier Ltd. All rights reserved.
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synovial membranes of patients with OA. Activated Th cells
stimulate monocytes to express several cytokines that contribute
to the development of OA through direct cellecell contact or
through soluble mediators such as interferon-g (IFN-g) and
IL-176,7. Th cells contribute to the pathogenesis of bone destructionFig. 1. Quantitation of CD4þ T cells in mice subjected to ACLT. (A) Using ACLT, OA was induc
groups (n¼ 4) were collected and stained for surface CD4þ on days 30, 60, and 90. The numb
splenocytes. (B) Splenocytes of four mice per group were pooled and stained for surface CD4
T cells/1106 splenocytes. Data are representative of two independent experiments. (C) Syn
stained with antibody against CD4þ (400 magniﬁcation). (D) Immunohistochemical staini
group mice, which showed no IFN-g expression on day 30 (200 magniﬁcation).under the active control of osteoblasts and osteoclasts. Activated
Th cells regulate osteoclastogenesis through the receptor acti-
vator of nuclear factor-kB ligand (RANKL) and IFN-g8. Osteoclast
activation leads to bone resorption and subsequent destruction.
Nevertheless, the mechanism of how Th cells affect osteoclasto-
genesis remains unclear.ed in the knee of one hind leg of mice on day 0. Splenocytes from the Sham and ACLT
er of CD4þ T cells (mean 95% CI) is expressed as the percentage of CD4þ T cells/1106
and CD44 on days 30, 60, and 90. Data are expressed as the percentage of CD4þ/CD44þ
ovial membranes from the Sham and ACLT groups on days 30, 60, 90 were removed and
ng showed higher IFN-g expression in the synovium of ACLT group mice than of Sham
Fig. 2. Evaluation of histological changes in the knee joints after the onset of ACLT-
induced OA. (A) Proliferation of synovial lining cells was mildly greater in CD4þ dep/
ACLT group mice than in Sham group mice on day 60. More severe synovitis occurred
in ACLT group mice than in CD4þ dep/ACLT mice on day 90 (Hematoxylin and eosin
stain; 200 magniﬁcation). (B) Histological examination showed a signiﬁcantly higher
synovitis score in the tissues from the knees of ACLT group mice on day 90. Data shown
are means 95% CI (n¼ 5 per group).
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analysis in an anterior cruciate ligament-transection (ACLT) model
of OA inwild-type mice and in CD4þ T cell knockout (CD4/) mice.
Methods
Animal models
Seven-week-old male B6 and CD4þ T cell knockout (CD4/)
mice were purchased from the Laboratory Animal Center of
National Cheng Kung University. The experimental protocol
adhered to the rules of the Animal Protection Act of Taiwan andwas
approved by the university’s Laboratory Animal Care and Use
Committee. The mice were divided into groups that were not
subjected to ACLT (Sham-group) and that were subjected to ACLT
(ACLT group, CD4þ dep/ACLT group and CD4//ACLT group). The
mice in ACLT group are wild-type mice. The mice in CD4þ dep/ACLT
group are wild-type mice undergoing temporary CD4þ T cell
depletion. The mice in CD4//ACLT group are CD4þ T cell knockout
mice. To induce experimental OA, each ACLT-group mouse was
anesthetized with tiletamine hydrochloride and zolazepam
hydrochloride (10 mg/kg) (Zoletil 50; Virbac, Carros, France) and
then subjected to a modiﬁed ACLT procedure9.
Flow cytometry
Splenocytes from the Sham and ACLT groups (n¼ 4 per group)
werecollectedondays30, 60, and90afterACLT. Splenocytes (1106
per analysis) were either single-stained with PE-conjugated-anti-
CD4 (L3T4; BD Biosciences, San Jose, CA, USA) or double-stained
with PE-conjugated-anti-CD4 and FITC-conjugated-anti-CD44
(Pgp-1; BD Biosciences) monoclonal antibodies for an hour at 4C.
The cells were then washed twice with staining buffer and sus-
pended in Roswell Park Memorial Institute (RPMI)-based buffer for
ﬂow cytometric analysis.
Depleting CD4þ T cells in mice
To produce mice with a temporary depletion of CD4þ T cells
(CD4þ dep), we intraperitoneally injected wild-type mice (n¼ 5)
with anti-mouse CD4 (GK1.5) monoclonal antibody 7 days before
ACLT. To efﬁciently deplete the CD4þ T-cell population, the anti-
body treatment was repeated at 10-day intervals until the day
before the mice were killed. CD4þ T cell depletion (>90%) from
splenocytes was conﬁrmed using ﬂow cytometry with anti-CD4
monoclonal antibodies (L3T4; BD Biosciences).
Immunohistochemistry and histological assessment
To analyze CD4þ Tcell inﬁltrates in the synovium, ACLTwas used
to induce OA in wild-type mice (n¼ 4), which were then killed 30,
60, and 90 days later. Their synovial membranes were removed,
ﬁxed, and embedded in parafﬁn. Serial sections (5 mm thick) were
cut and then incubated with rat anti-mouse CD4 (L3T4) (1:100;
H129.19; BDBiosciences Pharmingen, SanDiego, CA, USA) and IFN-g
(1:100; Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibodies at
4C overnight. To test CD3,macrophage inﬂammatory protein (MIP-
1g), Mac-3 antibody and matrix metalloproteinase (MMP)-9
expression, the samples from joints were prepared from wild-type
and CD4/mice (n¼ 4 per group). Serial sections of cartilage were
stained with hamster anti-mouse CD3 antibody (1:100) (BD
Biosciences Pharmingen), rabbit anti-mouse MIP-1g antibody
(1:100) (Peprotech, Rocky Hill, NJ, USA), Mac-3 (1:100) (BD Biosci-
ences Pharmingen) and MMP-9 (1:100) (Santa Cruz Biotechnology)
at 4C overnight. After they had been sequentially incubated withthe appropriate secondary antibody (1:400) (Jackson ImmunoR-
esearch Laboratories, Inc., West Grove, PA, USA) for 2 h at room
temperaturewith aminoethyl carbazole as the substrate chromogen
(Invitrogen Zymed Laboratories, Camarillo, CA, USA), the slideswere
counterstained with hematoxylin and eosin.
To evaluate the effect of CD4þ T cells at different stages of OA,
ACLTwas used to induce OA (n¼ 5 per group) inwild-typemice that
CD4þ T cells had been temporary depleted (CD4þ dep/ACLT). These
micewerekilled 30, 60, and90days later. Their synovialmembranes
were removed, ﬁxed, and embedded in parafﬁn. Serial sections
(5 mm thick) were cut and stained with hematoxylin and eosin. To
test for the histopathologic changes of cartilage in CD4þ T cell
knockout mice, ACLT was used to induce OA (CD4//ACLT) (n¼ 4
per group). On day 45 and 90, the cartilage and synovium were
processed for staining with Safranin-O/fast green and hematoxylin
and eosin. The histologic change in cartilage was scored using
Mankin’s histologic grading method3,10. The histologic changes in
synovial surface tissue and subsynovial tissue were evaluated and
scored3,11. Brieﬂy, the grading system assigns separate scores based
on two categories: (1) three subcategories of the synovial lining
layer: [i] hyperplasia of the synovial lining cells (0e3 points), [ii]
hypertrophy of the synovial lining layer (0e3 points), and [iii] the
inﬁltration of inﬂammatory cells (0e3 points); and (2) three
subcategories of the subsynovial tissue: [i] the proliferation of
granulation tissue (0e3points), [ii] vascularization (0e3points), [iii]
P.-C. Shen et al. / Osteoarthritis and Cartilage 19 (2011) 728e736 731and the inﬁltration of inﬂammatory cells (0e3 points). Total scores
in each categorywere calculated; themaximumscorewas 18points.
On day 90, both groups of mice (n¼ 6 per group) were killed and
their sera collected. The tartrate-resistant acid phosphatase (TRAP)
in mouse serum was assayed (MouseTRAP; Immunodiagnostic
Systems, Boldon, UK). Osteoclasts in tissues were identiﬁed by
histochemically staining TRAP using a commercial kit according to
the manufacturer’s instructions (Sigma, St Louis, MO, USA).Assessing MIP-1g and NF-kB expression
On day 90, the mice were killed, their joints skinned, and the
synovial tissue removed and dissected for homogenization in
phosphate-buffered saline (PBS) containing a protease inhibitor
cocktail. The homogenates from ﬁve mice in each group were
pooled.MIP-1g expression inmice after ACLTwas determined using
a mouse inﬂammation antibody array kit (RayBiotech, Atlanta, GA,
USA). The intensity of the signals was shown using a digital imaging
analysis system (Eastman Kodak Co., Rochester, NY, USA). The rela-
tive density was normalized with an internal control and expressed
as a ratio of the image density of each group divided by that of the
Sham group. To quantify theMIP-1g in tissue, mouse (n¼ 6)MIP-1g
levels in the homogenates were determined using an enzyme-
linked immunosorbent assay (ELISA) kit (R&D Systems, Minneap-
olis, MN, USA). To test NF-kB activity, the homogenates were
subjected to immunoblot analysis using antibodies against NF-kB
p65 antibody (1:1000) (93H1; Cell Signaling, Danvers, MA, USA).
b-actin expression was used as the quantitative control.Fig. 3. Proﬁle of inﬂammatory cytokines in mice with OA. (A) A cytokine array assay 90
expression and a markedly lower level of MIP-1g expression in CD4//ACLT group mice
normalized with the internal control and expressed as a ratio of the expression level of cy
represents the average of two replicated spots on the membrane. (C) MIP-1g expression wa
group mice (determined using ELISA). Values are means 95% CI.Statistical analysis
All data are represented as means plus 95% conﬁdence intervals
(CI). The quantiﬁcation of CD4þ Tcells, MIP-1g and TRAP proteins in
Figs. 1(A), 3(C), and 5(B) were analyzed using Student’s t test.
Signiﬁcance was set at P< 0.05. JMP 8.0 (SAS Institute Inc., Cary, NC,
USA) was used to analyze the histological data in Figs. 2(B), 6(C) and
Supplementary Fig. 2. Signiﬁcance between groups was estimated
using one-way analysis of variance (ANOVA). To evaluate the
differences between groups, we used Tukey’s Honestly Signiﬁcant
Difference test set at P< 0.05.
Results
CD4þ T cell activation during the progression of OA
To examine the alteration of CD4þ T cells in OA, ﬂow cytometry
was used to count the number of CD4þ T cells in splenocytes in the
Sham and ACLT groups. The number of CD4þ T cells signiﬁcantly
increased on day 30 in ACLT group mice compared to the Sham
group mice [27.6% (25.18e30.02) vs 23.1% (18.42e27.77), P¼ 0.017,
Fig. 1(A)], but the differences between the two groups on days 60
and 90 were not signiﬁcant. CD4þ T cell activation was further
tested. On day 30, the percentage of CD4þ/CD44þ T cells in the ACLT
group was 24.5%, higher than the 14.8% in the Sham group
[Fig. 1(B)]. The percentages declined in both groups on day 60
(12.8% vs 17.3%), and no difference detected on day 90 (17.0% vs
17.0%). Furthermore, notable increases of CD4þ Tcells inﬁltrated the
synovium of mice from the ACLT group on day 30. The numbers ofdays after ACLT treatment shows a mildly higher level of sTNF-RII, IL-4, and TIMP-1
(n¼ 5 per group) than in ACLT group mice. (B) The relative density of cytokines was
tokines in each group divided by the expression level in the Sham group. Each value
s signiﬁcantly higher in ACLT group mice (n¼ 6) than in Sham group and CD4//ACLT
Fig. 4. The inﬁltration of CD4þ T cells and MIP-1g expression in mice with OA.
Representative immunohistochemical images of the cartilage are shown (n¼ 4 per
group). (A) In the ACLT group mice, increased CD4þ T cell inﬁltration and MIP-1g
expressionwere seen in joints compared to those in the Sham and CD4//ACLT groups
90 days post-surgery (100 magniﬁcation, left panels). The overlapped locations of
CD4þ T cells and MIP-1g expression were indicated with arrows. The insets represent
the magniﬁed area (400 magniﬁcation, right panels). The CD4-positive and MIP-
1gepositive cells were indicated with arrow heads.
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detected on day 90 [Fig. 1(C)]. No signiﬁcant change was seen in
Sham group at the three time points. IFN-g was noticeably
expressed in synovial tissue from ACLT knee joints on day 30
[Fig. 1(D)], but barely detectable on days 60 and 90 (data not
shown).
In order to assess the effect of CD4þ T cells on OA progression,
CD4þ T cells were depleted in wild-type (CD4þ dep) mice and the
histopathologic changes analyzed. Synovial membranes from three
groups (Sham, CD4þ dep/ACLT, and ACLT) showed no signiﬁcant
alteration during the ﬁrst 2 months [Fig. 2(A)]. Specimens from the
ACLT group mice showed hyperplasia of the lining cells and
increased cell inﬁltration on day 90. Lesions from the CD4þ dep/
ACLT group mice were markedly less severe. The synovitis score in
the joints of ACLT group mice was signiﬁcantly higher than that in
CD4þ dep/ACLT on day 90 (P< 0.001) [Fig. 2(B)]. These results
suggest that CD4þ T cells may induce inﬂammation in the early
stage of OA, whereas the damage in cartilage caused by inﬂam-
mation is more prominent in the later stage.
Decreased MIP-1g expression in CD4/ mice
To identify the proteins affected by CD4þ T cells in cartilage, we
induced OA in CD4/ mice. Cytokine array analysis showed that
several cytokines and chemokinesdsoluble tumor necrosis factor
receptors II (sTNF-RII), IL-4, tissue inhibitor of metalloproteinase
(TIMP)-1, and MIP-1gdwere altered in the CD4//ACLT group
mice on day 90 after OA induction [Fig. 3(A)]. The sTNF-RII, IL-4,
TIMP-1 expressions were lower, whereas MIP-1g expression was
higher in the ACLTgroup than in the CD4//ACLTgroups [Fig. 3(B)].
This result was conﬁrmed using an ELISA assay. MIP-1g expression
was signiﬁcantly lower in the CD4//ACLT group [7673.26
(5916.08e9430.44) pg/ml] than in the ACLT group [20321.24
(17260e23382.95) pg/ml, P< 0.001] [Fig. 3(C)]. To detect the
distribution of CD4þ T cells and MIP-1g protein in joints, we per-
formed the immunohistochemistry on serial sections of cartilage.
No CD4þ T cells were detected in the CD4//ACLT group mice
whereas many CD4þ T cells were inﬁltrated throughout the syno-
vial membrane of the ACLT group mice (Fig. 4). The expression of
MIP-1g was only detected in the lower metaphysic of CD4//ACLT
group mice. Increased expression of MIP-1g was detected in the
synovium of ACLT group mice. Very few CD4þ T cells and MIP-1g
expression were detected in the bone marrows of the Sham group
mice. In the ACLT group mice, some MIP-1g expression could be
detected at the same locations where CD4þ T cells inﬁltrated
(arrows, Fig. 4). Furthermore, some locations of total T cells (CD3þ)
distribution were overlapped with those of MIP-1g expression in
ACLT group mice (Supplementary Fig. 1).
Decreased osteoclastogenesis in CD4/ mice
Because MIP-1g expression promotes osteoclast survival
through NF-kB activation, we next examined the expression of
activated NF-kB in mice. Ninety days after ACLT, NF-kB expression
in tissue homogenate was markedly lower in CD4//ACLT group
mice than in Sham and ACLTgroupmice [Fig. 5(A)]. The levels of the
osteoclast marker TRAP were signiﬁcantly lower in the serum of
CD4//ACLT group mice (1.18 (1.055e1.305) U/L) than in that of
ACLT group mice (2.59 (2.305e2.875) U/L, P< 0.001) [Fig. 5(B)].
Large, multinucleated osteoclasts adjacent to the calciﬁed cartilage
were prominent in ACLT group mice [Fig. 5(C)]. In addition, more
intense staining of TRAP in the proximal tibial growth plate of ACLT
group mice and its reduction in CD4//ACLT group mice was seen.
These results suggested that the expression ofMIP-1g and activated
NF-kB upregulated osteoclast levels. Increased MIP-1g expressionattracted macrophages into the synovium. Macrophage inﬁltration
is a major feature of tissue inﬂammation in OA. Ninety days after
ACLT, the relative number of Mac-3-positive macrophages that had
inﬁltrated the synovium was higher in ACLT group mice than in
CD4//ACLT group mice [Fig. 5(D)]. Given that MMP-9 is essential
for recruitment of osteoclast and activated CD4þ T cells stimulate
the degradation of extracellular matrix5,12, we measured the
expression of MMP-9 in the mice. MMP-9 expression was higher in
the cartilage of ACLT mice than CD4//ACLT mice [Fig. 5(E)].Evaluation of histological changes and MIP-1g expression on the
cartilages of ACLT-induced OA
Histopathological examination of the knee joints of ACLT group
mice revealed loss of proteoglycan on day 45 and more severe
Fig. 5. The suppression of osteoclastogenesis after ACLT in CD4/mice. (A) NF-kB expression levels were higher in ACLT group mice than in CD4//ACLT group mice. (B) The serum
levels of TRAP were signiﬁcantly lower in CD4//ACLT mice (n¼ 6 per group) than in ACLT group mice. (C) TRAP staining reveals that fewer osteoclasts (arrows) were formed
between the cartilage and subchondral bone layer (upper panel) and tibial metaphysis (lower panel) in CD4//ACLT group mice (n¼ 4 per group) when compared to ACLT group
ones (400 magniﬁcation). Cart, cartilage layer; SB, subchondral bone layer. (D) The relative number of Mac-3-positive macrophages (200 magniﬁcation) in the subsynovial tissue
of ACLT group mice was higher than that of CD4//ACLT group mice. Synovial membranes from the Sham group mice showed no signiﬁcant staining. (E) Immunohistochemical
staining showed higher MMP-9 expression in the cartilage from the ACLT group mice than from the CD4//ACLT group mice (200 magniﬁcation).
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as hypocellularity was seen on day 90. However, the disease
progression in CD4//ACLT group was slower. Specimens from
CD4//ACLT group mice showed a mild irregularity on the surface
on day 45, and decrease in cartilage thickness in the posterior of the
femur on day 90 [Fig. 6(A)]. Most of the articular cartilage in the
knee joints of Sham groupmice had a smooth surface. The synovitis
occurred in ACLT group mice was more severe than in CD4//ACLT
group mice 90 days post-surgery (Supplementary Fig. 2). The
expression of MIP-1gwas only detected in the lower metaphysic in
Sham and CD4//ACLT groups at all time [Fig. 6(B)]. The staining of
MIP-1g can be detected in the synovium of ACLT groups on day 45and the MIP-1gepositive cells were evident in the chondro-
osseous junction on day 90. Mankin’s scores of joints from ACLT
group mice were signiﬁcantly higher than those of joints from
CD4//ACLT mice on day 90 (P¼ 0.002) [Fig. 6(C)]. Taken together,
these results indicated that the loss of Th cells potently alleviated
inﬂammation and cartilage damage by inhibiting MIP-1g
expression.
Discussion
To determine the potential effect of Th cells on OA development,
we induced OA in the knee joints of CD4/ mice (CD4//ACLT).
Fig. 6. Evaluation of histological changes and MIP-1g expression on the cartilages of ACLT-induced OA. Representative histology images of the cartilage on the medial femoral
condyle are shown. (A) The ACLT group mice showed more aggressive cartilage damage (n¼ 4 per group). The chondrocyte loss was noted on day 45, and the disease progressed to
a disappearance of the surface layer cells on day 90 (Safranin-O/fast green stain, 200 magniﬁcation). In the CD4//ACLT group mice, the specimen showed a proteoglycan
reduction and ﬁssures in the superﬁcial cartilaginous layer (arrow) on day 90. In the Sham group, the superﬁcial cartilaginous layer shows a smooth and regular surface. (B) The
MIP-1gepositive cells were visible in the synovium and in the chondro-osseous junction along with disease progression in ACLT group mice. The expression of MIP-1g was
restricted in the lower metaphysis in the Sham and CD4//ACLT groups mice as indicated with arrows (400 magniﬁcation). (C) A histological examination showed lower Mankin’s
scores in the joints from CD4//ACLT group mice than in those from ACLT group mice. Data shown are mean 95% CI.
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1gdin the knee joints of CD4//ACLT mice were changed. The ﬁrst
three proteins showed amild increase, whereas theMIP-1g showed
a signiﬁcant reduction. sTNF-RII and IL-4 are both believed to haveanti-inﬂammatory functions during disease progression13,14. Four
members of the TIMP familydTIMP-1, -2, -3, and -4dhave been
characterized15. TIMP-1 is a dominant cartilage TIMP that inhibits
all collagenase, including MMP-116. The equilibrium between
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absence of CD4þ T cells may ameliorate the OA symptoms partially
through the suppression of these anti-inﬂammatory factors. The
most obvious alteration in protein level was in MIP-1g. ELISA
showed an approximately 62% reduction of MIP-1g expression
from the cartilage homogenate of CD4//ACLT mice when OA was
induced. MIP-1g belongs to a CeC chemokine family containing
MIP-1a, MIP-lb, MIP-1g, regulated upon activation, normal T cell
expressed and secreted (RANTES) etc. MIP-1g is produced by
monocytes and other types of leukocytes. Through binding to
chemokine receptor 1 (CCR1), a speciﬁc receptor on neutrophils,
MIP-1g acts as a chemoattractant that induces the chemotaxis of
CD4þ T cells, CD8þ T cells, and monocytes18,19. In the synovium of
ACLT group mice, some locations of T cells inﬁltration and MIP-1g
expression were overlapped, but others were not. It is because that
T cells themselves may produce MIP-1g directly or they can stim-
ulate other cells, such as macrophages to produce MIP-1g through
RANKL signaling pathway. These inﬁltrating immune cells are
responsible for orchestrating immune and inﬂammatory responses
in synovium. In fact, the levels of two other members of the MIP-1
chemokine family, MIP-1a and MIP-lb, have been reported to be
increased in the synovial ﬂuid of patients with rheumatoid
arthritis20,21. The roles of MIP-1g in patients with arthritic diseases
have not yet been clariﬁed. MIP-1g promoted osteoclast formation
and survival through the RANKL pathway22,23. Bone-resorbing
osteoclasts coordinately interplay with osteoblasts and remodel
bone through highly regulated molecular and cellular events. The
activity of the osteoclast marker TRAP was remarkably reduced in
the serum of CD4//ACLT mice. In contrast, the osteoclast forma-
tion was increased in both subchondral bone and metaphyseal
surfaces in the joints of ACLT group mice. The staining of MIP-1g
was also more evident in the chondro-osseous junction of mice on
day 90 after ACLT. The expression of MIP-1g could promote oste-
oclast motility24. Therefore, the similarly expressed locations of
MIP-1g and osteoclast markers indicate that bone erosion induced
by MIP-1g may occur here. Our results suggested that CD4þ T cells
regulate the activity of osteoclasts through MIP-1g protein
expression during the progression of OA.
The RANKL signaling pathway derived from Th cells is
responsible for pathologic osteoclastogenesis and focal erosion in
arthritis23. However, T cells also have a negative regulatory
mechanism for inhibiting osteoclastogenesis. IFN-g and IL-4
produced by the CD4þ T cell subsets Th1 and Th2, respectively,
showed an anti-osteoclastogenic effect on arthritis25,26. We found
IFN-g expression but no apparent cartilage damage 30 days after
OA had been induced; however, 90 days after OA had been
induced, we found no IFN-g expression but did ﬁnd severe
cartilage and bone damage. Th cell-induced IFN-g expression may
compromise the activation of osteoclasts and subsequent carti-
lage damage in the early stage of OA. Th17 cells, a new CD4þ T
cell subset, have been identiﬁed as being primarily responsible
for inducing receptor activator of nuclear factor-kB (RANK)27,
thus causing osteoclast activation. IL-17 produced by Th17 also
induced the production of MMP-9 in osteoclasts28. Furthermore,
the secreted IL-17 induces the expression of three chemokines
(monocyte chemotactic protein (MCP)-1, MIP-2, and TIMP-1), and
MMP-9 in ﬁbroblasts, and attracts both monocytes and neutro-
phils to the inﬂammatory focus29. Consistent with these ﬁndings,
our data showed that monocyte aggregation and MMP-9 staining
were more prominent 90 days after OA had been induced. Our
results showed that the number of CD4þ T cells inﬁltrating the
synovium gradually fell during the disease progression. We
suspect that in the early stage of OA, during which a large
number of Th cells is activated, Th1 and Th2 cells and the cyto-
kines they induce are important for initiating OA. During theprogression of OA, some Th cells (probably Th17 cells) may
continuously cause subsequent exacerbation despite a decrease in
the number of Th cells. This possibility needs to be examined in
additional studies. Our data suggest that temporal activation of
CD4þ T cells may affect the way in which OA manifests itself.
Our study had some limitations. First, because of the signiﬁcant
involvement of CD4þ T cells in OA, in this study, their effect on the
pathogenesis of OA was focused. Nevertheless, we could not rule
out the potential role of CD8þ cytotoxic T cells here, because CD3þ T
cells (the common marker of both CD4þ and CD8þ T cells) have
been found in the angiocentric inﬁltrates from the synovial
membrane of patients and with OA5. Our results also showed that
CD3þ T cells were detected in the synovium of mice with OA. In
addition, CD8þ T cells speciﬁc for common herpes viruses, such as
EpsteineBarr virus and cytomegalovirus, have also been nonspe-
ciﬁcally trapped, although in fewer patients with OA than in
patients with rheumatoid arthritis, at the sites of inﬂammation in
the synovium30. Whether these CD8þ T cells recruited in synovium
after viral infection are involved in OA is unclear. In a preliminary
study (unpublished observations), we found that the number of
CD8þ Tcells and TIMP-1 expression changed during OA progression
in CD8þ Tcells knockoutmice. How CD8þ Tcells affect this gene and
the putative functions of the CD8þ T cells involved in OA are under
investigation. Second, we used ACLT-induced OA in our study.
Based on the histological observation of animal models, we clas-
siﬁed day 90 after ACLT treatment as the “late stage” of OA and
examined the changes in cytokine expression at this time point.
The actual development of OA in humans can persist for several
years. Although the pathogenic characteristics of themice in our OA
animal model and in patients with OA are similar, ACLT-induced OA
can not be completely translated into the clinical setting. Because
cytokines ﬂuctuate during the progression of OA, we could not rule
out the possibility that other cytokines affected by CD4þ T cells
participate in the development of OA.
In conclusion, we showed that CD4þ T cells were involved in the
initiation of OA in a mouse ACLT model. Cytokine array analysis
showed that MIP-1g protein expression was signiﬁcantly lower in
CD4//ACLT mice. MIP-1g protein may be responsible for osteo-
clast formation and joint destruction in the later stage of OA. We
conclude that MIP-1g protein is a potential therapeutic target for
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